Sun Pharma, Cadila Healthcare recall products from US market1 min read . Updated: 30 Nov 2016, 08:39 PM IST
Zydus Pharmaceuticals USA is recalling 2,472 units of Bupropion Hydrochloride extended release tablets manufactured by Ahmedabad-based Cadila Healthcare
New Delhi: The US-based subsidiaries of two domestic drug firms—Sun Pharma and Cadila Healthcare—are recalling one product each from the market on account of failure to meet the desired specification norms.
Select your Category